1 recruiting, 1 terminated. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 1, Terminated 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Malignant Lymphoma, Non-Hodgkin: new trials by email Literature Review of Malignant Lymphoma, Non-Hodgkin trials Research Report on Malignant Lymphoma, Non-Hodgkin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Preventing of GVHD with Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Ruxolitinib At Children and Young Adults with Hemoblastosis Conditioning regimen: Treosulfan 42 g/m2/course or total body irradiation 12 Gray/course, Etoposide 60 mg/kg , Fludarabine 150 - Biphenotypic Acute Leukemia, Acute Lymphoblastic Leukemia | Phase 2 / Phase 3 | Recruiting | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 50 | 2024-07-10 | 2025-01-01 |
| Phase 2 Poor Risk DLBCL of TLI and ATG Followed by Matched Allogeneic HT as Consolidation to Autologous HCT Autologous hematopoietic stem cell transplantation (auto-HSCT), Allogeneic hematopoietic stem cell transplantation (allo-HSCT), Total lymphoid irradiation (TLI) - Lymphoma, B-cell, Lymphoma, Non-Hodgkin | Phase 2 | Terminated | Stanford University | 3 | 2006-10-01 | 2018-05-14 |
Lymphoma, Non-Hodgkin (2) · Leukemia, Biphenotypic, Acute (1) · Leukemia, Myelomonocytic, Acute (1) · Lymphoma, B-Cell (1) · Lymphoma, Large B-Cell, Diffuse (1) · Myelodysplastic Syndromes (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Hemic and Lymphatic Diseases (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Lymphatic Diseases (2) · Lymphoma (2) · Lymphoproliferative Disorders (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Bone Marrow Diseases (1) · Hematologic Diseases (1) · Leukemia (1) · Leukemia, Lymphoid (1) · Leukemia, Myeloid (1)
Etoposide (2) · Acetaminophen (1) · Antilymphocyte Serum (1) · Carmustine (1) · Cyclophosphamide (1) · Cyclosporine (1) · Diphenhydramine (1) · Filgrastim (1) · Granulocyte Colony-Stimulating Factor (1) · Hydrocortisone (1) · Methylprednisolone (1) · Methylprednisolone Hemisuccinate (1) · Mycophenolic Acid (1) · Rituximab (1) · Transplantation (1)
Federal Research Institute of Pediatric Hematology, Oncology and Immunology (1) · Stanford University (1)
Russia (1) · United States (1)
Wen-Kai Weng (1)